Inozyme Pharma Inc.

Inozyme Pharma Inc.

World Rank (Jan-05-2024)
16,447
Market Cap (Jan-05-2024)
0.265 Billion USD
World Rank (Jul-30-2023)
17,663
Market Cap (Jul-30-2023)
0.216 Billion USD
World Rank (Jan-07-2022)
20,454
Market Cap (Jan-07-2022)
0.154 Billion USD
World Rank (Jan-01-2021)
11,327
Market Cap (Jan-01-2021)
0.482 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
INZY
Headquarters City/State
Massachusetts
World Region
Americas
World Subregion
Northern America
Business Sector
Healthcare
Biopharmaceutical
Biotechnology
Company Website
INOZYME PHARMA, INC.
Company Profile
Inozyme Pharma is a Rare Disease Biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization impacting the vasculature, soft tissue and skeleton. The company estimated annual revenue is currently 7.4 million USD per year. The headquarters is in USA.
IPO Year
2020
Stock Exchange
Nasdaq
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share